FDA Greenlights Healgen's At-Home COVID-19/Flu Test, Boosts Respiratory Illness Detection

October 9, 2024
FDA Greenlights Healgen's At-Home COVID-19/Flu Test, Boosts Respiratory Illness Detection
  • The test is intended for individuals aged 14 years or older for self-collection, or for samples collected from younger individuals (aged 2 years or older) by adults, and should be used within the first 5 days of symptom onset.

  • Dr. Michelle Tarver from the FDA emphasized the test's significance as the flu season approaches, enhancing home-testing options for respiratory illnesses.

  • The FDA has authorized Healgen Scientific's Rapid Check COVID-19/Flu A&B Antigen Test for home use without a prescription, marking a significant milestone for the company.

  • This test is specifically designed for individuals experiencing respiratory symptoms and is notable for being marketed through the traditional approval pathway rather than under emergency use.

  • The authorization aims to enhance the ability to detect respiratory illnesses effectively at home as flu season approaches.

  • Healgen's CEO, Bingliang Fang, highlighted that the test provides a reliable and user-friendly option for at-home diagnostics, facilitating early diagnosis and treatment.

  • Clinical studies indicated the test correctly identified 99% of negative SARS-CoV-2 samples and 92% of positive samples, along with high accuracy for Flu A and B.

  • The Healgen home tests are expected to be available over the counter by Thanksgiving 2023, priced between $13 and $16 each, sold through retailers such as CVS and Amazon.

  • Healgen plans to increase production of the respiratory tests to meet the anticipated demand for the upcoming fall respiratory season, according to company president Bryan Fang.

  • The FDA recommends taking the test if experiencing respiratory symptoms, but individuals showing symptoms should seek healthcare advice regardless of test results.

  • The authorization was announced on a Monday, coinciding with the availability of four free COVID-19 tests per household from the U.S. Department of Health and Human Services.

  • The FDA warns of potential false negative results, advising individuals with ongoing symptoms to consult their healthcare provider, even if test results are negative.

Summary based on 9 sources


Get a daily email with more Science stories

More Stories